Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis.
Saved in:
| Title: | Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis. |
|---|---|
| Authors: | Ahmad T; Department of Pharmaceutical Medicine, Division of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Adil M; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Azharuddin M; Department of Pharmaceutical Medicine, Division of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Ansari S; Institute of Health Management Research - Bangalore, Karnataka 560105, India., Vohora D; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India., Sharma M; Department of Pharmaceutical Medicine, Division of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. |
| Source: | Current reviews in clinical and experimental pharmacology [Curr Rev Clin Exp Pharmacol] 2025 Jul 09. Date of Electronic Publication: 2025 Jul 09. |
| Publication Type: | Journal Article; Meta-Analysis |
| Journal Info: | Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 9918227368306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-4336 (Electronic) Linking ISSN: 27724328 NLM ISO Abbreviation: Curr Rev Clin Exp Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
